BIA
LLY icon

Bigelow Investment Advisors’s Eli Lilly LLY Stock Holding History

Bigelow Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593K Buy
645
+41
+7% +$41.6K 0.24% 97
2025
Q4 		$649K Sell
604
-48
-7% -$45.9K 0.25% 94
2025
Q3 		$497K Buy
652
+95
+17% +$70.7K 0.2% 115
2025
Q2 		$434K Buy
557
+43
+8% +$33.4K 0.19% 119
2025
Q1 		$425K Buy
+514
New +$428K 0.2% 113

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bigelow Investment Advisors's LLY Position: Q1 2026 in Review

Bigelow Investment Advisors increased its Eli Lilly (LLY) stake by 6.8% in Q1 2026, buying an estimated $41.6K and bringing the position to 645 shares worth $593K. The position accounts for 0.24% of the portfolio, ranked #97.

Bigelow Investment Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $649K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bigelow Investment Advisors held 645 shares of Eli Lilly worth $593K as of Q1 2026.
  • Bigelow Investment Advisors bought 41 Eli Lilly shares in Q1 2026, an estimated $41.6K.
  • Eli Lilly made up 0.24% of Bigelow Investment Advisors's portfolio in Q1 2026, its #97 holding.
  • Bigelow Investment Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Bigelow Investment Advisors's Eli Lilly position peaked at $649K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bigelow Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.